Real-World Analysis of the Efficacy and Adverse Events of T-DM1 in Chinese Patients With HER2-Positive Breast Cancer
This retrospective study demonstrated that AEs were associated with tumour efficacy in patients with HER2+ BC treated with TDM1.
Authors
- S N Qi
- Teng Zhu (ORCID: https://orcid.org/0000-0002-1754-4878)
- Jie Ding (ORCID: https://orcid.org/0000-0001-9093-5907)
- Huayan Gu
- Gui-Long Guo (ORCID: https://orcid.org/0000-0002-6614-4360)
- Zhi Yang (ORCID: https://orcid.org/0009-0003-1586-3001)
Institutions
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
Publication Details
- Journal
- Breast Cancer Targets and Therapy
- Published
- 2025-02-01
- DOI
- https://doi.org/10.2147/bctt.s503150
- Citations
- 1
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 1.05